This Federal Supply Schedule (FSS) contract with Mitsubishi Tanabe Pharma America, Inc. was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, on December 15, 2017. The contract has a ceiling value of $26,441,930.00 and a period of performance through December 31, 2023.
The contract is for the provision of 65 IB, Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Master GSA Schedule. As a multiple-award contract, this allows VISN 12 to procure these pharmaceutical and drug-related products and services from Mitsubishi Tanabe Pharma America, Inc. and potentially other vendors holding contracts under the same FSS schedule. The contract does not utilize any set-aside designations. Mitsubishi Tanabe Pharma America, Inc. is a for-profit, foreign-owned organization registered in SAM.gov through June 15, 2025.
Generated 9/7/24, 11:14 AM